Vitamin K Dose for Newborns Calculator

Enter the newborn's birth weight, gestational age, and preferred route of administration to calculate the recommended vitamin K prophylaxis dose per AAP and WHO guidelines.

Created by Luis GonzalezLast updated: May 9, 2026

How to Use This Calculator

1
Enter Newborn Birth Weight
Input the newborn's birth weight in kilograms. Infants weighing less than 1.5 kg receive a reduced dose.
2
Specify Gestational Age
Enter the gestational age in completed weeks. Preterm infants may have specific protocol adjustments.
3
Select Route of Administration
Choose 'Intramuscular (IM)' for the preferred single dose or 'Oral' for the 3-dose regimen.
4
Review Recommended Dose
The calculator will display the recommended vitamin K dose, dose per kg, and protection level.

Example Calculation

A term newborn weighing 3.3 kg is due for vitamin K prophylaxis via intramuscular injection.

Birth Weight

3.3 kg

Gestational Age

39 weeks

Route of Administration

Intramuscular (IM) — Preferred

Results

1.0 mg

Tips

IM Route is Gold Standard

The intramuscular (IM) injection is the preferred and most effective method for vitamin K prophylaxis, providing immediate and sustained protection against early and late VKDB.

Oral Regimen Requires Adherence

If the oral route is chosen, strict adherence to the 3-dose regimen (at birth, 4-6 days, 4-6 weeks) is crucial, as missed doses significantly increase the risk of Vitamin K Deficiency Bleeding.

Preterm Infants May Need Adjustments

Preterm infants, especially those under 1.5 kg, often receive a reduced IM dose (0.5 mg) and may require further individualized protocols based on their clinical status and local NICU guidelines.

Calculating Newborn Vitamin K Dosing for Optimal Prophylaxis

The Vitamin K Dose for Newborns Calculator helps healthcare providers determine the recommended prophylactic dose based on birth weight, gestational age, and administration route. This tool supports adherence to clinical guidelines, ensuring newborns receive the correct dosage to prevent Vitamin K Deficiency Bleeding (VKDB). Understanding these precise requirements is a critical aspect of neonatal care in 2025, safeguarding against a potentially life-threatening condition.

Preventing Hemorrhagic Disease of the Newborn

Vitamin K prophylaxis is a universal standard of care for newborns, essential for preventing Hemorrhagic Disease of the Newborn (HDN), also known as Vitamin K Deficiency Bleeding (VKDB). Newborns are born with very low levels of vitamin K, a critical co-factor for the synthesis of clotting proteins in the liver. Without adequate vitamin K, infants are at risk of spontaneous and severe bleeding, which can occur in the brain (intracranial hemorrhage), gastrointestinal tract, or skin. The American Academy of Pediatrics (AAP) and the World Health Organization (WHO) universally recommend a single intramuscular (IM) dose of vitamin K shortly after birth, citing its proven efficacy in reducing the incidence of early, classical, and late VKDB, which can have devastating consequences if left untreated. This simple intervention dramatically reduces the risk of bleeding complications from an estimated 1 in 10,000 to virtually zero.

The Logic Behind Newborn Vitamin K Dosing

The Vitamin K Dose for Newborns Calculator applies established medical guidelines for prophylactic administration. The dosage is primarily determined by the newborn's birth weight and the chosen route of administration (intramuscular or oral).

The core logic is as follows:

Intramuscular (IM) Dose:
- For newborns weighing < 1.5 kg: 0.5 mg IM
- For newborns weighing ≥ 1.5 kg: 1.0 mg IM
Oral Dose:
- A standard 3-dose regimen is used, with each administration being 2.0 mg. The total oral course is 3 doses × 2.0 mg = 6.0 mg.
- The oral regimen typically involves doses at birth, 4–6 days, and 4–6 weeks.

The calculator determines the recommendedDose based on the selected route and calculates dosePerKg for further clinical context. Gestational age is noted for awareness, as preterm infants may have additional nuanced protocols.

💡 After birth, tracking a newborn's growth is crucial for health; our Birth Weight to Discharge Weight Calculator can help monitor weight changes.

Calculating Vitamin K for a Term Newborn

Let's consider a term newborn (39 weeks gestational age) weighing 3.3 kg, for whom an intramuscular (IM) vitamin K injection is planned.

Birth Weight: Enter "3.3" kg.
Gestational Age: Enter "39" weeks.
Route of Administration: Select "Intramuscular (IM)".

The calculator performs the following:

IM Dose: Since the birth weight (3.3 kg) is ≥ 1.5 kg, the recommended IM dose is 1.0 mg.
Dose per kg: 1.0 mg / 3.3 kg = 0.303 mg/kg.
Total Oral Course: (Not applicable for IM, but would be 1.0 mg for comparison as a single IM dose).
Protection Level: "Optimal".

The primary result, "IM Dose: 1.0 mg", provides the precise amount for administration, confirming the standard protocol for a full-term infant.

💡 For parents planning ahead, understanding how to safely store breast milk is also vital; our Breast Milk Storage Duration Calculator provides useful guidance.

Global Guidelines for Newborn Vitamin K Prophylaxis

Vitamin K prophylaxis for newborns is a globally accepted practice, with consensus recommendations from leading health organizations like the World Health Organization (WHO), the American Academy of Pediatrics (AAP), and the UK's National Institute for Health and Care Excellence (NICE). The primary recommendation across these bodies is a single intramuscular (IM) dose of 0.5 mg for infants weighing less than 1.5 kg and 1.0 mg for infants weighing 1.5 kg or more, given within the first six hours of birth. This IM route is preferred due to its superior efficacy in preventing both early and late forms of Vitamin K Deficiency Bleeding (VKDB), offering sustained protection. While an oral 3-dose regimen (2 mg at birth, 2 mg at 4-7 days, and 2 mg at 4-6 weeks) is an alternative, especially in countries where IM administration is less common or declined by parents, it is generally considered less protective against late VKDB due to potential compliance issues and variable absorption. Preterm infants, particularly those under 32 weeks gestational age, may require individualized protocols based on their clinical stability and the specific guidelines of the neonatal intensive care unit (NICU).

Global Guidelines for Newborn Vitamin K Prophylaxis

Vitamin K prophylaxis for newborns is a globally accepted practice, with consensus recommendations from leading health organizations like the World Health Organization (WHO), the American Academy of Pediatrics (AAP), and the UK's National Institute for Health and Care Excellence (NICE). The primary recommendation across these bodies is a single intramuscular (IM) dose of 0.5 mg for infants weighing less than 1.5 kg and 1.0 mg for infants weighing 1.5 kg or more, given within the first six hours of birth. This IM route is preferred due to its superior efficacy in preventing both early and late forms of Vitamin K Deficiency Bleeding (VKDB), offering sustained protection. While an oral 3-dose regimen (2 mg at birth, 2 mg at 4-7 days, and 2 mg at 4-6 weeks) is an alternative, especially in countries where IM administration is less common or declined by parents, it is generally considered less protective against late VKDB due to potential compliance issues and variable absorption, as highlighted by numerous meta-analyses showing higher VKDB rates with oral administration compared to IM.

Frequently Asked Questions

Why is vitamin K given to newborns?

Vitamin K is given to newborns as a prophylactic measure to prevent Vitamin K Deficiency Bleeding (VKDB), a potentially life-threatening bleeding disorder. Newborns have very low vitamin K stores at birth because it does not cross the placenta efficiently, and their gut flora, which typically produces vitamin K, is not yet fully developed. A single dose of vitamin K ensures adequate clotting factor synthesis, protecting against unexpected and severe bleeding in the brain or other organs. The American Academy of Pediatrics (AAP) recommends universal administration.

What is Vitamin K Deficiency Bleeding (VKDB)?

Vitamin K Deficiency Bleeding (VKDB) is a serious bleeding disorder that can affect newborns who do not receive prophylactic vitamin K at birth. It occurs because vitamin K is essential for the production of clotting factors in the liver. Without sufficient vitamin K, these factors cannot be activated, leading to impaired blood clotting. VKDB can manifest as bruising, gastrointestinal bleeding, or, most dangerously, intracranial hemorrhage, which can cause permanent brain damage or death. Its incidence is significantly reduced with routine vitamin K administration.

What is the difference between IM and oral vitamin K administration?

Intramuscular (IM) administration involves a single injection of vitamin K into the newborn's muscle, providing immediate and reliable protection against VKDB. This is the preferred route due to its high efficacy and compliance. Oral administration, conversely, requires a three-dose regimen (at birth, 4-6 days, and 4-6 weeks) to achieve comparable protection. The oral route is less effective at preventing late VKDB due to potential poor absorption and the risk of missed doses, making it a secondary option typically chosen when IM is declined by parents.

How does birth weight affect the vitamin K dose?

Birth weight is a critical factor in determining the appropriate vitamin K dose for newborns. For most full-term infants weighing 1.5 kg or more, the standard intramuscular dose is 1 milligram (mg). However, for very low birth weight (VLBW) infants, specifically those weighing less than 1.5 kg, a reduced dose of 0.5 mg is typically recommended. This adjustment is made to account for their smaller size and immature physiological systems, ensuring effective prophylaxis while minimizing potential risks associated with higher concentrations in smaller bodies.